| 1 |
What is the primary function of AI in the medical imaging industry?
|
|
|
AI can improve medical practice by improving productivity and patient outcomes. |
AI helps by automating image analysis, supporting diagnosis, and streamlining workflows to assist healthcare professionals in delivering faster and more accurate medical imaging services. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
Acting as a second medical opinion is a key benefit of AI in radiology and medical imaging. |
AI systems often support radiologists by providing automated analyses and highlighting findings. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
It includes how AI systems work, their capabilities, limitations, and appropriate use within clinical settings. |
AI literacy influenced how comfortable and confident healthcare professionals feel. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of machines doesn't really affect trust, or other important factors. |
The study focuses on trust, understanding, workflow, ethical concerns, and other important factors more than machine color. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
People shaped their trust for AI by their thoughts. |
It shapes their attitudes and willingness to adopt AI tools based on the opinions. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
People don't trust AI as much as real doctors or professionals. |
They concern that AI might undermine their professional identity, autonomy, or job security. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
People will trust AI more with human feeling centered inside AI. |
It's about creating tools that fit well into how medical professionals work and think, making them easier and safer to use within healthcare settings. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
If AIs don't interrupt their workflow, people tend to use them more. |
These factors are key to whether healthcare professionals find AI practical and acceptable to use in their daily work. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethicality affects people’ views on AI based on its compatibility with their profession. |
If an AI system aligns with core medical ethics, professionals are more likely to view it as acceptable. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
The article emphasizes the importance of deeply considering user experience and system integration to increase AI acceptability among people. |
Successful AI adoption in healthcare depends not just on technical performance, but also their compatibility. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
|
|
The main objective is to replace the lost dopaminergic neurons in the brain that are responsible for motor symptoms of PD. |
Parkinson’s disease is characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
Rats are commonly used to test in almost every single experiment about organism. |
The study in a preclinical rat model of Parkinson’s disease showed that the transplanted cells led to full functional recovery. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
39 weeks is approximately 9 months. |
The preclinical safety study in rats lasted about 9 months to thoroughly assess toxicity, tumorigenicity, and biodistribution of the STEM-PD product. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
These phases allows researchers to efficiently evaluate both safety and early effectiveness of the stem cell therapy in Parkinson’s patients. |
This designation indicates that the trial is designed to assess both Phase I and Phase IIa of the stem cell-derived dopaminergic neuron therapy in patients with Parkinson's disease. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
GMP manufacturing is about controlled processes, and thorough quality testing.
|
It followed strict regulatory standards to ensure high quality, consistency, safety and purity. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
According to the article, the safety of the STEM-PD product in rats was confirmed by a 39-week GLP. |
The study found no adverse effects, providing strong evidence that the STEM-PD product is safe for further clinical testing. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The efficacy study of STEM-PD in rats shows that the transplanted dopaminergic neurons mediated full functional recovery. |
This showed that the stem cell-derived neurons could restore motor function impaired by Parkinson’s-like symptoms. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
FOXA2 is a transcription factor critical for specifying the midbrain floor plate.
OTX2 is a transcription factor about early brain patterning. |
These transcription would help ensure that the stem cell-derived neurons have the appropriate characteristics of the target cell type. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
Ventral midbrain dopaminergic neurons are the target cell type for the disease therapy. |
These growth factors will assure that the cells develop the correct identity and function needed for effective transplantation. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
The key outcome was the recovery of motor function in the rats with Parkinson’s disease. |
This showed that the transplanted stem cell–derived dopaminergic neurons could restore the movement deficits. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|